Children as hematopoietic cell donors in research: when is it approvable?

Area of Science:

• Pediatric Hematology
• Medical Ethics
• Clinical Research Regulations

Background:

• Allogeneic hematopoietic cell transplantation (HCT) in children is growing in research settings.
• Minor siblings frequently serve as hematopoietic stem cell (HSC) donors for pediatric HCT.
• Current federal regulations for pediatric research lack clarity regarding minor HSC donors.

Purpose of the Study:

• To review ethical and regulatory issues concerning minor HSC donors in pediatric research.
• To identify gaps in current understanding and areas requiring further investigation.
• To propose a framework for determining minor donor eligibility and regulatory approval.

Main Methods:

• Literature review of federal regulations on human subject research.
• Analysis of ethical considerations in pediatric research involving minors.
• Development of a proposed framework for evaluating minor HSC donors.

Main Results:

• Uncertainty exists regarding the applicability of pediatric research regulations to minor HSC donors.
• Existing regulations may not adequately address the unique situation of child donors.
• A structured approach is needed to assess when minor donors are considered human research subjects.

Conclusions:

• Clear guidelines are needed to navigate the ethical and regulatory landscape of minor HSC donors.
• The proposed framework aims to assist in determining when minor donors' participation is permissible under federal law.
• Further research and policy development are essential for protecting minor donors in cellular therapies.